Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,034 | 952 | 99.6% |
| Education | $46.25 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,401 | 93 | $0 (2024) |
| Amgen Inc. | $1,332 | 86 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,120 | 77 | $0 (2024) |
| Lilly USA, LLC | $1,068 | 98 | $0 (2024) |
| ABBVIE INC. | $889.30 | 75 | $0 (2024) |
| PFIZER INC. | $751.24 | 67 | $0 (2024) |
| Novo Nordisk Inc | $683.60 | 51 | $0 (2024) |
| Astellas Pharma US Inc | $679.46 | 43 | $0 (2024) |
| Merck Sharp & Dohme LLC | $465.22 | 46 | $0 (2023) |
| Amarin Pharma Inc. | $413.82 | 26 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,322 | 81 | GlaxoSmithKline, LLC. ($220.46) |
| 2023 | $1,511 | 103 | GlaxoSmithKline, LLC. ($274.43) |
| 2022 | $2,007 | 130 | ABBVIE INC. ($327.91) |
| 2021 | $1,607 | 120 | Amgen Inc. ($299.72) |
| 2020 | $1,546 | 99 | Amarin Pharma Inc. ($303.43) |
| 2019 | $1,557 | 123 | AstraZeneca Pharmaceuticals LP ($305.10) |
| 2018 | $1,541 | 125 | AstraZeneca Pharmaceuticals LP ($305.55) |
| 2017 | $1,990 | 178 | AstraZeneca Pharmaceuticals LP ($257.95) |
All Payment Transactions
959 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Gastroenterology | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VACCINES | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Biological | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: PAIN | ||||||
| 10/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: PAIN | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,322 | 1,532 | $191,145 | $56,040 |
| 2022 | 16 | 1,295 | 1,619 | $176,914 | $54,080 |
| 2021 | 18 | 1,373 | 1,627 | $187,828 | $80,036 |
| 2020 | 18 | 1,269 | 1,467 | $255,282 | $63,433 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 219 | 323 | $48,127 | $13,716 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 239 | 249 | $50,103 | $12,316 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 205 | 205 | $38,130 | $9,005 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 186 | $18,796 | $6,636 | 35.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 64 | 66 | $5,096 | $4,659 | 91.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 116 | 131 | $6,437 | $2,244 | 34.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 28 | 28 | $7,728 | $2,040 | 26.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 67 | $2,680 | $1,865 | 69.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 26 | 27 | $4,077 | $1,611 | 39.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 89 | 96 | $5,184 | $714.70 | 13.8% |
| 70220 | X-ray of paranasal sinus, minimum of 3 views | Office | 2023 | 25 | 25 | $2,000 | $470.24 | 23.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $841.00 | $331.12 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 36 | $1,440 | $292.32 | 20.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 50 | 52 | $338.00 | $112.20 | 33.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 12 | 12 | $168.00 | $27.99 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 389 | $57,961 | $17,340 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 231 | $23,331 | $8,528 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 165 | 165 | $30,690 | $7,556 | 24.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 153 | 161 | $32,361 | $7,472 | 23.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 58 | 58 | $4,366 | $3,962 | 90.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 143 | 161 | $7,889 | $3,200 | 40.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $2,320 | $1,526 | 65.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 12 | $3,816 | $1,089 | 28.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 110 | 116 | $6,264 | $931.54 | 14.9% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 14 | 23 | $2,070 | $883.07 | 42.7% |
About Dr. Thomas Moore, MD
Dr. Thomas Moore, MD is a Family Medicine healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780677666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Moore, MD has received a total of $13,080 in payments from pharmaceutical and medical device companies, with $1,322 received in 2024. These payments were reported across 959 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($13,034).
As a Medicare-enrolled provider, Moore has provided services to 5,259 Medicare beneficiaries, totaling 6,245 services with total Medicare billing of $253,589. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Little Rock, AR
- Active Since 08/26/2005
- Last Updated 07/14/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780677666
Products in Payments
- FARXIGA (Drug) $957.71
- Aimovig (Biological) $706.87
- TRELEGY ELLIPTA (Drug) $663.52
- NURTEC ODT (Drug) $590.89
- Otezla (Drug) $450.62
- UBRELVY (Drug) $421.84
- MYRBETRIQ (Drug) $415.97
- Vascepa (Drug) $413.82
- VRAYLAR (Drug) $324.02
- SHINGRIX (Biological) $317.46
- MOUNJARO (Drug) $299.46
- TRULICITY (Drug) $293.06
- QULIPTA (Drug) $282.05
- Ozempic (Drug) $225.36
- EMGALITY (Drug) $219.02
- Trintellix (Drug) $213.86
- JANUVIA (Drug) $210.24
- JARDIANCE (Drug) $202.17
- INVOKANA (Drug) $193.21
- XIFAXAN (Drug) $186.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Little Rock
Dr. Kevin Roberts, Md, MD
Family Medicine — Payments: $133,330
Dr. Derek Lewis, M.d, M.D
Family Medicine — Payments: $117,470
Dr. Harold Betton, M.d, M.D
Family Medicine — Payments: $23,468
Dr. Oksana Melnyk, M.d, M.D
Family Medicine — Payments: $14,185
Benjamin Mcdonald, D.o, D.O
Family Medicine — Payments: $13,868
Dr. J . Timothy Hodges, Md, MD
Family Medicine — Payments: $13,633